* USANA Health Sciences Inc reported quarterly adjusted earnings of 56 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 59 cents. The mean expectation of two analysts for the quarter was for earnings of 49 cents per share. Wall Street expected results to range from 46 cents to 51 cents per share.

* Revenue fell 6.2% to $200.22 million from a year ago; analysts expected $205.77 million.

* USANA Health Sciences Inc's reported EPS for the quarter was 56 cents​.

* The company reported quarterly net income of $10.61 million.

* USANA Health Sciences Inc shares had fallen by 7.6% this quarter and lost 34.6% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts was unchanged in the last three months.​

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the food processing peer group is also "hold"

Wall Street's median 12-month price target for USANA Health Sciences Inc is 46.50 This summary was machine generated from LSEG data October 23 at 04:14 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 0.49 0.56 Beat

Jun. 30 2024 0.65 0.54 Missed

Mar. 31 2024 0.69 0.86 Beat

Dec. 31 2023 0.52 0.87 Beat